These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18671662

  • 41. [Excerpts from the clinical-pharmacologic and clinical studies of Grandaxin].
    Szegó J, Somogyi M, Papp E.
    Acta Pharm Hung; 1993 Mar; 63(2):91-8. PubMed ID: 8100114
    [Abstract] [Full Text] [Related]

  • 42. Open retropubic colposuspension for urinary incontinence in women: a short version Cochrane review.
    Lapitan MC, Cody JD, Grant A.
    Neurourol Urodyn; 2009 Mar; 28(6):472-80. PubMed ID: 19591206
    [Abstract] [Full Text] [Related]

  • 43. Self-harm and suicide associated with benzodiazepine usage.
    Neale G, Smith AJ.
    Br J Gen Pract; 2007 May; 57(538):407-8. PubMed ID: 17504594
    [Abstract] [Full Text] [Related]

  • 44. Benzodiazepines revisited.
    Balon R.
    Psychother Psychosom; 2013 May; 82(6):353-4. PubMed ID: 24061158
    [No Abstract] [Full Text] [Related]

  • 45. Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan.
    Uchida H, Suzuki T, Mamo DC, Mulsant BH, Kikuchi T, Takeuchi H, Tomita M, Watanabe K, Yagi G, Kashima H.
    J Anxiety Disord; 2009 May; 23(4):477-81. PubMed ID: 19010641
    [Abstract] [Full Text] [Related]

  • 46. [Benzodiazepines are the right choice i certain anxiety disorders. A recent report from the WHO confirms the evidence-based experience].
    Strömstedt A.
    Lakartidningen; 1998 Aug 26; 95(35):3696-9. PubMed ID: 9748784
    [No Abstract] [Full Text] [Related]

  • 47. [When and how to stop anxiolytic drugs].
    Nuss P.
    Rev Prat; 1999 Sep 15; 49(14 Suppl):S36-41. PubMed ID: 10887616
    [Abstract] [Full Text] [Related]

  • 48. Retrospective evaluation of the effects of diazepam in dogs with anxiety-related behavior problems.
    Herron ME, Shofer FS, Reisner IR.
    J Am Vet Med Assoc; 2008 Nov 01; 233(9):1420-4. PubMed ID: 18980494
    [Abstract] [Full Text] [Related]

  • 49. Comments on article by Mitte and associates: "A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder".
    Magalhães PV.
    J Clin Psychopharmacol; 2006 Apr 01; 26(2):220-1; author reply 221. PubMed ID: 16633161
    [No Abstract] [Full Text] [Related]

  • 50. Herbal and dietary supplements for treatment of anxiety disorders.
    Saeed SA, Bloch RM, Antonacci DJ.
    Am Fam Physician; 2007 Aug 15; 76(4):549-56. PubMed ID: 17853630
    [Abstract] [Full Text] [Related]

  • 51. Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder.
    Lalovic B, Hutmacher M, Frame B, Miller R.
    J Clin Pharmacol; 2011 May 15; 51(5):706-18. PubMed ID: 20663989
    [Abstract] [Full Text] [Related]

  • 52. Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety.
    Rickels K, Moeller HJ.
    World J Biol Psychiatry; 2019 Sep 15; 20(7):514-518. PubMed ID: 30252578
    [Abstract] [Full Text] [Related]

  • 53. [The mnemonic effects of benzodiazepines].
    Peretti CS, Debacq C.
    Rev Prat; 1999 Sep 15; 49(14 Suppl):S30-5. PubMed ID: 10887615
    [Abstract] [Full Text] [Related]

  • 54. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun 15; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 55. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L, Manchikanti KN, Pampati V, Cash KA.
    Pain Physician; 2009 Jun 15; 12(1):259-67. PubMed ID: 19165308
    [Abstract] [Full Text] [Related]

  • 56. Benzodiazepines and addiction.
    Juergens SM.
    Psychiatr Clin North Am; 1993 Mar 15; 16(1):75-86. PubMed ID: 8096077
    [Abstract] [Full Text] [Related]

  • 57. Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives.
    Longo LP, Johnson B.
    Am Fam Physician; 2000 Apr 01; 61(7):2121-8. PubMed ID: 10779253
    [Abstract] [Full Text] [Related]

  • 58. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B.
    Rev Neurol (Paris); 2008 Nov 01; 164(11):917-26. PubMed ID: 18790510
    [Abstract] [Full Text] [Related]

  • 59. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.
    Encephale; 2008 Oct 01; 34(5):526-33. PubMed ID: 19068343
    [Abstract] [Full Text] [Related]

  • 60. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov 01; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.